Skip to content

Dexmedetomidine Affect Diabetic Patient's Glucose Metabolism

Perioperative Dexmedetomidine Affect Diabetic Patient's Glucose Metabolism

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02510612
Acronym
dadpgm
Enrollment
120
Registered
2015-07-29
Start date
2015-08-31
Completion date
2016-12-31
Last updated
2015-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

Dexmedetomidine, Diabetic, glycometabolism, sedation

Brief summary

Dexmedetomidine's Sedative Effect on Diabetic Patient

Detailed description

Dexmedetomidine is a high selective α2 agonist,its sedative and analgesia feature is acclaimed. The pathogenesis of type 2 diabetes mellitus is associated with α2 excessive adrenaline receptors expression. This study is to evaluate whether the use of dexmedetomidine is helpful to Diabetic Patient through its antisympathetic effect

Interventions

DRUGDexmedetomidine

During anesthesia induction, all patients will be given propofol,fentanyl,vecuronium bromide.But before induction start in Dexmedetomidine(D) group, patient will be given dexmedetomidine 1μg/Kg for 10 minutes In anesthesia maintenance, D group will be given dexmedetomidine 0.4μg/Kg.h until 40 minutes before the end of surgery

DRUGplacebo

During anesthesia induction, all patients will be given propofol,fentanyl,vecuronium bromide.But before induction start in Placebo(P) group, patient will be given placebo for 10 minutes In anesthesia maintenance, D group will be given placebo until 40 minutes before the end of surgery

Sponsors

Shaanxi Provincial People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
40 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Age between 40 and 60 * Selective epigastrium surgery * In

Exclusion criteria

* American Society of Anesthesiology (ASA) Physical Status\>3 * Duration of operation \>3 hours * Hypovolemia,sinus bradycardia,atrioventricular block,severe hepatic and renal dysfunction,severe cardiac insufficiency

Design outcomes

Primary

MeasureTime frameDescription
sedation levelfrom 5 minutes before medication to 10 minutes after Dexmedetomidine discontinuance,length of time frame is about 2 hoursRamsay score and BIS will be recorded before medication,5 min after medication, medication ending, 5 and 10 min after medication

Secondary

MeasureTime frameDescription
Mean arterial pressureparticipants will be followed from operation day to first postoperative day,an expected average of 2 days10 min after medication, before intubation, after intubation, after skin incision,60 minutes after skin incision, after extubation,first day after operation
blood glucose measured by Biochemical testparticipants will be followed from operation day to first postoperative day,an expected average of 2 daysit will be recorded immediately after the entrance to the operating room, before operation, 60 minutes after incision, after extubation, first day after operation
cortisol measured by Biochemical testparticipants will be followed from operation day to first postoperative day,an expected average of 2 daysit will be recorded immediately after the entrance to the operating room, before operation, 60 minutes after incision, after extubation, first day after operation
Heart rateparticipants will be followed from operation day to first postoperative day,an expected average of 2 daysrecorded at before medication,5 min after medication, medication ending, 5 and 10 min after medication, before intubation, after intubation, after skin incision,60 minutes after skin incision, after extubation,first day after operation
adrenaline measured by Biochemical testparticipants will be followed from operation day to first postoperative day,an expected average of 2 daysit will be recorded immediately after the entrance to the operating room, before operation, 60 minutes after incision, after extubation, first day after operation
noradrenaline measured by Biochemical testparticipants will be followed from operation day to first postoperative day,an expected average of 2 daysit will be recorded immediately after the entrance to the operating room, before operation, 60 minutes after incision, after extubation, first day after operation
insulin measured by Biochemical testparticipants will be followed from operation day to first postoperative day,an expected average of 2 daysit will be recorded immediately after the entrance to the operating room, before operation, 60 minutes after incision, after extubation, first day after operation

Contacts

Primary ContactYulong Song
86-13519185656

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026